Journal of Biosciences and Medicines 2025

3 papers
The 2025 edition of the Journal of Biosciences and Medicines focuses on molecular pharmacology, oncology, and clinical diagnostic modeling. Research themes emphasize metabolic reprogramming and immune evasion within tumor microenvironments, specifically addressing how metabolic plasticity contributes to immunotherapy resistance. Key studies investigate the development of TDO target inhibitors and the molecular determinants of biological potency in peptide drug design, with a focus on overcoming proteolytic degradation. The year's publications also highlight advancements in clinical risk assessment and diagnostic integration. Research directions include the use of tree ensembles and longitudinal data for dynamic risk stratification, as seen in studies on perioperative venous thrombosis in colorectal cancer patients. Other investigations explore the link between neuroinflammation and tinnitus, alongside the translational challenges in preclinical biomedical research. Prolific contributors such as Andy Peng Xiang, Shuang Cao, and Yong-Shou Chen have focused on multi-parametric integration for disease diagnostics, reflecting a trend toward using complex data sets to improve clinical outcomes.

Top Research Directions

The 12 research directions with Journal of Biosciences and Medicines 2025 papers, ranked by paper count, next to 2024. Share is the fraction of the edition’s papers in the direction.

#Direction20252024Share 2025Share 20242024 rank
1Bypassing the Blood-Brain Barrier for Central Nervous System Therapeutics1033.3%0.0%—
2Composite Multi-Marker Diagnostic Panels1033.3%0.0%—
3Dynamic Temporal Modeling for Clinical Risk Assessment1033.3%0.0%—
4Gradient Boosted Decision Trees for Non-linear Clinical Modeling1033.3%0.0%—
5Metabolic Barriers to Anti-Tumor Immunity1033.3%0.0%—
6Metabolic Reprogramming of the Tumor Microenvironment1033.3%0.0%—
7Optimizing Chemical Scaffolds for Therapeutic Efficacy1033.3%0.0%—
8Optimizing Dosing and Sequencing for Synergistic Combination Therapies1033.3%0.0%—
9Overcoming the Blood Brain Barrier for CNS Drug Delivery1033.3%0.0%—
10Overcoming the Metabolic Instability of Peptide Therapeutics1033.3%0.0%—
11The External Validation Gap in Clinical Machine Learning1033.3%0.0%—
12The Preclinical to Clinical Translation Gap1033.3%0.0%—

Download all directions as CSV

Institutions

Institutions credited by Journal of Biosciences and Medicines 2025 papers: a paper credits every institution named in its affiliations, once. 3 institutions share 3 credited papers.

#InstitutionPapersShare20242024 rank
100wemg618 133.3%0—
2Wuhan Institute of Technology 133.3%0—
3Yangtze University 133.3%11

Download all institutions as CSV

About this data

Papers. Journal of Biosciences and Medicines 2025 lists 3 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2024 use shares, since the edition went from 4 to 3 papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 3 of 3 papers (100.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Journal of Biosciences and Medicines 2025”, https://lacuna.tiptreesystems.com/venue/journal-of-biosciences-and-medicines/2025.

Top Authors

AuthorPapers
Jin Liu1

Impactful Papers

Papers from Journal of Biosciences and Medicines 2025 that shaped research clusters.

Influential

Papers

Title
Advances in Risk Factors and Assessment Tools for Perioperative Venous Thrombosis in Colorectal Cancer Patients
Research Progress of Tinnitus and Neuroinflammation
TDO Target Inhibitor Research Progress Review